Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease

Retrieved on: 2022-08-04 18:27:05

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease. View article details on hiswai:

Excerpt

THURSDAY, Aug. 4, 2022 (HealthDay News) -- The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson ...

Article found on: www.physiciansweekly.com